Perioperativer Umgang mit Thrombozytenaggregationshemmern

@article{Wagner2017PerioperativerUM,
  title={Perioperativer Umgang mit Thrombozytenaggregationshemmern},
  author={Johanna Wagner and J. F. Lock and Verena Luber and Ulrich Andreas Dietz and Sven Lichthardt and Niels Matthes and Katica Krajinovic and Christoph T. Germer and Stefan Knop and Armin Wiegering},
  journal={Der Chirurg},
  year={2017},
  volume={89},
  pages={90-94}
}
ZusammenfassungPro Jahr werden in Deutschland ca. 16 Mio. operative Eingriffe durchgeführt. Eine nicht unerhebliche Anzahl an Patienten nehmen Thrombozytenaggregationshemmer als Primär- oder Sekundärprophylaxe ein, um das Risiko kardiovaskulärer Ereignisse zu reduzieren. Besonders in der perioperativen Phase ist diese Risikoreduktion relevant, da perioperative Myokardinfarkte in bis zu 6,2 % der Operationen festgestellt wurden. Andererseits wird aufgrund des mutmaßlich erhöhten Blutungsrisikos… 
3 Citations
Sicherheit durch patientenorientierte moderne Medizin
Das deutsche Gesundheitssystem bietet hervorragende Rahmenbedingungen fur eine patientenorientierte moderne Medizin. Aber nicht alles ist gesetzlich zu regeln und gute Strukturen sind alleine kein

References

SHOWING 1-10 OF 33 REFERENCES
Anticoagulation and antiplatelet therapy in urological practice: ICUD/AUA review paper.
Prasugrel versus clopidogrel in patients with acute coronary syndromes.
TLDR
In patients with acute coronary syndromes with scheduled percutaneous coronary intervention, prasugrel therapy was associated with significantly reduced rates of ischemic events, including stent thrombosis, but with an increased risk of major bleeding, including fatal bleeding.
Impact of preoperative maintenance or interruption of aspirin on thrombotic and bleeding events after elective non-cardiac surgery: the multicentre, randomized, blinded, placebo-controlled, STRATAGEM trial.
TLDR
In these at-risk patients undergoing elective non-cardiac surgery, there did not find any difference in terms of occurrence of major thrombotic or bleeding events between preoperative maintenance or interruption of aspirin.
Clopidogrel response status assessed with Multiplate point-of-care analysis and the incidence and timing of stent thrombosis over six months following coronary stenting.
TLDR
Six-month follow-up results of a prospective trial assessing clopidogrel responsiveness with MEA in patients undergoing percutaneous coronary intervention (PCI) show a significant inverse correlation of MEA values and the timing of definite or probable ST (in days) was observed, with events occurring earlier in the low-responder group.
Comparison of preoperative continuation and discontinuation of aspirin in patients undergoing total hip or knee arthroplasty
TLDR
The data support perioperative continuation of aspirin intake in patients undergoing total hip or knee arthroplasty and suggest Continuation of aspirin may be associated with a favourable peri operative cardiac outcome.
...
...